Andere Sprachen Psyence Group Inc.

Aktien

A2QNE2

CA74449Q1063

PSYG

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 21:47:41 03.05.2024			% 5 Tage	% 1. Jan.
0.02 ^CAD	0.00%		-33.33%	-60.00%

26.03.	Ein nicht genannter Käufer hat die Übernahme von Mind Health (Pty) Ltd und Psyence Uk Group Ltd von Psyence Group Inc. (CNSX:PSYG) abgeschlossen.	CI
11.03.	Psyence Group Inc. gibt den Rücktritt von Neil Maresky als CEO bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	16.04.
Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	26.03.
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business	26.03.
An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	26.03.
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	12.03.
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	12.03.
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11.03.
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11.03.
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11.03.
Psyence Group Inc. Announces Resignation of Neil Maresky as CEO	11.03.
Psyence Group Inc. Announces CFO Changes	11.03.
Psyence Group Inc. Announces Board Resignations	11.03.
An undisclosed buyer entered into a conditional agreement to acquire Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc. for CAD 1 million.	11.03.
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28.02.
Psyence Biomedical Approved to List on Nasdaq Following Completion of Business Combination With Newcourt Acquisition Corp	26.01.
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	26.01.
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	25.01.
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination	16.01.
Psyence Group Inc. Announces Resignation of Marvin Singer as Board Member	20.11.
Psyence Group Announces Resignation of Board Member	20.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Psyence Group Inc.

Aktien

A2QNE2

CA74449Q1063

PSYG

Andere Sprachen

Filter